Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study
Open Access
- 11 February 2014
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 37 (3) , 718-724
Abstract
OBJECTIVE To identify the clinical and genetic factors that explain why the rate of diabetes progression is highly variable between idividuals following diagnosis of type 2 diabetes. RESEARCH DESIGN AND METHODS We studied 5,250 patients with type 2 diabetes using comprehensive electronic medical records in Tayside, Scotland, from 1992 onward. We investigated the association of clinical, biochemical, and genetic factors with the risk of progression of type 2 diabetes from diagnosis to the requirement of insulin treatment (defined as insulin treatment or HbA1c ≥8.5% [69 mmol/mol] treated with two or more noninsulin therapies). RESULTS Risk of progression was associated with both low and high BMI. In an analysis stratified by BMI and HbA1c at diagnosis, faster progression was independently associated with younger age at diagnosis, higher log triacylglyceride (TG) concentrations (hazard ratio [HR] 1.28 per mmol/L [95% CI 1.15–1.42]) and lower HDL concentrations (HR 0.70 per mmol/L [95% CI 0.55–0.87]). A high Genetic Risk Score derived from 61 diabetes risk variants was associated with a younger age at diagnosis and a younger age when starting insulin but was not associated with the progression rate from diabetes to the requirement of insulin treatment. CONCLUSIONS Increased TG and low HDL levels are independently associated with increased rate of progression of diabetes. The genetic factors that predispose to diabetes are different from those that cause rapid progression of diabetes, suggesting a difference in biological process that needs further investigation.Keywords
This publication has 24 references indexed in Scilit:
- Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathwaysNature Genetics, 2012
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetesNature Genetics, 2012
- Risk models and scores for type 2 diabetes: systematic reviewBMJ, 2011
- Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetesDiabetes & Metabolism, 2010
- β-Cell deterioration during diabetes: what's in the gun?Trends in Endocrinology & Metabolism, 2009
- Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 DiabetesNew England Journal of Medicine, 2008
- Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With the Glutathione S Transferase Theta–Null GenotypeCirculation, 2005
- Cardiovascular Risk in Type 2 Diabetes Is Associated With Variation at the PPARG LocusArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Deteriorating beta‐cell function in type 2 diabetes: a long‐term modelQJM: An International Journal of Medicine, 2003
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999